Introduction Refractory headache is a common and frequently disabling disorder, affecting 2–12 million patients each year in ...

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...

Background Endovascular treatment (EVT) is an important treatment for symptomatic intracranial atherosclerotic stenosis (sICAS). However, restenosis limits its long-term efficacy, and some patients ...

Background The impact of parent artery stenosis on the treatment of intracranial aneurysms by using flow diversion (FD) remains unknown. This multicenter retrospective study aimed to evaluate the ...

Background Neutrophil-to-lymphocyte ratio (NLR) is a prognostic indicator in intracerebral hemorrhage (ICH) thought to reflect systemic inflammation driving secondary brain injury. Recent evidence ...

Objective Aqueductal stenosis is a common cause of obstructive hydrocephalus, resulting in ventricular dilation and neurological deterioration. Standard treatments such as shunting, endoscopic third ...

Background Endovascular thrombectomy achieves macroreperfusion in large vessel occlusion (LVO) stroke, but only one-quarter of patients had excellent functional outcome. Adjunct intra-arterial (IA) ...

Background and purpose Flow diverters (FDs) have become one of the primary treatments for intracranial aneurysms (IAs). However, their use in distal IA has been associated with higher complication ...

Objective To evaluate the potential of pericarotid adipose tissue radiomics to improve the prediction of in-stent restenosis (ISR) after carotid artery stenting (CAS). Methods This retrospective study ...

Introduction Headache is a common and disabling symptom after aneurysmal subarachnoid hemorrhage (aSAH), often requiring high-dose opioids. Meningeal inflammation and dural nociceptor activation may ...

Neurointervention is a highly specialized area of medicine and, as such, neurointerventional research studies are often more challenging to conduct, require large, multicenter efforts and longer study ...

Background Middle meningeal artery embolization (MMAE) is a promising treatment for non-acute subdural hematoma (NASDH), but trial evidence is limited by heterogeneity and open label design bias. This ...